← Back to all trials
Completed
NCT02915107
The SORT OUT IX STEMI OCT Trial
Conditions: Acute Myocardial Infarction
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 80
Sponsor: Odense University Hospital
Location: Aarhus University Hospital Aarhus
Summary
The aim of the Danish Organization for Randomized Trials with Clinical Outcome (SORT OUT) IX STEMI OCT is to compare early vascular healing of the polymer-free Biolimus-eluting BIOFREEDOM stent with a biodegradable-polymer Sirolimus-eluting ORSIRO stent in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI).
Eligibility Criteria
Inclusion Criteria:
* Patients aged 18 years or over with STEMI, requiring treatment with a drug-eluting stent.
Exclusion Criteria:
* life expectancy of less than one year; an allergy to aspirin, clopidogrel, ticagrelor, prasugral, biolimus or sirolimus; participation in another randomized trial; chronic renal disease; or inability to provide written informed consent.
Source: ClinicalTrials.gov (NCT02915107). StuddyBuddy aggregates publicly available trial information.
